ScopusElsevier Scopus
Status
Inactive/Discontinued
Coverage
2013–2024
Source type
Journal
Open access
No
SJR · SCImago
0.392
Q2 SJR quartile
H-index
30
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Expert Opinion on Orphan Drugs
Expert Opinion on Orphan Drugs is not currently indexed in Scopus. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 2167-8707Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Scopus · Inactive
0
Indexed in
Cost to publish: No APC data — check the publisher
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Expert Opinion on Orphan Drugs indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2013–2024).
What is the impact factor of Expert Opinion on Orphan Drugs?
Expert Opinion on Orphan Drugs has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.392, quartile Q2, with an H-index of 30.
Who publishes Expert Opinion on Orphan Drugs and what is its ISSN?
Expert Opinion on Orphan Drugs is published by Taylor and Francis Ltd. Its ISSN is 2167-8707.
Is Expert Opinion on Orphan Drugs in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Expert Opinion on Orphan Drugs open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
Scopus coverage history
Scopus indexed Expert Opinion on Orphan Drugs for 12 years, between 2013 and 2024. Coverage ended in 2024, 2 years ago, and Scopus now lists the title as inactive.
Is it still publishing? OpenAlex lists 862 works and 5,447 citations for the title. Its most recent paper is from 2024, in line with the end of Scopus coverage in 2024, which suggests the journal stopped publishing around then.
How well cited is Expert Opinion on Orphan Drugs? — open metrics via OpenAlex
Expert Opinion on Orphan Drugs has an h-index of 34 and a 2-year mean of 14.4 citations per paper (OpenAlex).
34
h-index
14.4
2-yr mean citations
148
i10-index
862
works indexed
5,447
total citations
Expert Opinion on Orphan Drugs published 5 papers in 2024; its busiest recent year was 2015 with 150. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Who publishes in Expert Opinion on Orphan Drugs? — latest 42 articles, 2021–2024
In its latest 42 research articles (2021–2024), authors are most often from United States (25.2%), United Kingdom (20.4%) and Italy (13.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Expert Opinion on Orphan Drugs? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2024. 2 retracted papers are recorded (2.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2024
- Retracted papers 2 · 2.3 per 1,000 papers
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from Taylor and Francis Ltd.
Taylor and Francis Ltd. has 1596 other titles in our data; 1206 are currently indexed in Scopus.
Journal Scopus status
AAC: Augmentative and Alternative Communication Active Accountability in Research Active Acta Agriculturae Scandinavica - Section A: Animal Science Active Acta Agriculturae Scandinavica Section B: Soil and Plant Science Active Acta Cardiologica Active Acta Chirurgica Belgica Active Related journals
8 journals Journal Indexed in
Expert Opinion on Pharmacotherapy Scopus Q2 WoS SCIE Expert Opinion on Therapeutic Patents Scopus Q1 WoS SCIE Expert Opinion on Therapeutic Targets Scopus Q1 WoS SCIE Expert Review of Anti-Infective Therapy Scopus Q1 WoS SCIE Expert Review of Anticancer Therapy Scopus Q2 WoS SCIE Expert Review of Cardiovascular Therapy Scopus Q2 WoS ESCI Expert Review of Clinical Immunology Scopus Q2 WoS SCIE Expert Review of Clinical Pharmacology Scopus Q1 WoS SCIE
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.